Antigenic Relationships among Five Reovirus-Like (RVL) Agents by Complement Fixation (CF) and Development of New Substitute CF Antigens for the Human RVL Agent of Infantile Gastroenteritis
Antigenic Relationships among Five Reovirus-Like (RVL) Agents by Complement Fixation (CF) and Development of New Substitute CF Antigens for the Human RVL Agent of Infantile Gastroenteritis
复制标题
通过补体固定 (CF) 确定五种呼肠孤病毒样 (RVL) 制剂之间的抗原关系以及开发婴儿胃肠炎人 RVL 制剂的新替代 CF 抗原
DOI:
10.3181/00379727-152-39434
复制
发表时间:
1976
影响因子:
--
通讯作者:
Annie L. Vaughn
中科院分区:
文献类型:
--
作者:
A. Kapikian;W. Cline;Hyun W. Kim;A. Kalica;R. Wyatt;D. Vankirk;R. Chanock;H. James;Annie L. Vaughn
Summary The human reovirus-like (HRVL) agent, Nebraska calf diarrhea virus (NCDV), epizootic diarrhea of infant mice (EDIM) virus, simian agent (SA)-11, and the “O” (offal) agent were found to be similar, if not identical, in reciprocal complement fixation (CF) tests employing hyperimmune animal sera. In addition, in CF tests with paired sera from 35 diarrhea patients who shed the HRVL agent, 74% developed serologic evidence of infection with the HRVL antigen, 43% with NCDV, 51% with EDIM virus, 57% with SA-11, and 71% with the “O” agent. Thus, in addition to the NCDV, which had previously been described as a suitable substitute CF antigen for the HRVL agent, the SA-11, “O,” and EDIM viruses may also be utilized as substitute antigens for the HRVL agent. However, the “O” agent appears to be the most efficient of the four substitute CF antigens and thus should be used preferentially when the HRVL agent is not available. The “O” agent was about as efficient as the HRVL agent and significantly more efficient than the NCDV for detecting seroresponses. The greatest efficiency for detecting infection with the HRVL agent resulted when sera were tested with both the HRVL and “O” agents as 31 (89%) of the patients developed serologic evidence of infection with one or both antigens. The finding of additional substitute CF antigens for the HRVL agent may have implications in the immuno-prophylaxis against human disease. We thank Dr. D. W. Alling for assistance in statistical analyses and Mr. C. E. Banks, Mr. E. Williams, Mr. B. Andrews, Mr. J. P. Jackson, Miss D. M. Bertran, Mrs. S. J. Kelly, Mr. Robert P. Chames, Mrs. L. P. Kendrick, Mr. C. S. Osborne, Mrs. B. V. Armiger, and Mrs. C. L. Armiger for assistance in these studies.